2025
SJR Q2
JCR Q3 · 2,8
94 matched articles
SCIE
Journal detail
Pharmacology
- Publisher
- S. Karger AG
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
0031701214230313
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,81
- Quartile Q2
- H-Index 73
- Cites/doc 2,47
- Docs (3y) 160
- Cites (3y) 492
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,8
- 5Y JIF 3
- JCI 0,67
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Pharmacology Q2
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,81 | 2,8 | 3 | 0,67 | Q2 | 73 |
| 2024 | Q2 | Q2 | 0,74 | 3,2 | 2,6 | 0,69 | Q2 | 70 |
| 2023 | Q2 | Q2 | 0,679 | 2,9 | 2,5 | 0,74 | Q2 | 70 |
| 2022 | Q2 | Q3 | 0,551 | 3,1 | 2,6 | 0,83 | Q2 | 70 |
| 2021 | Q3 | Q3 | 0,432 | 3,4 | 2,6 | 0,83 | Q2 | 70 |
| 2020 | Q3 | Q3 | 0,51 | 2,5 | 2,2 | 0,67 | Q3 | 70 |
| 2019 | Q2 | Q4 | 0,457 | 1,6 | 1,6 | 0,53 | Q3 | 70 |
| 2018 | — | Q4 | — | 1,6 | 1,6 | 0,52 | Q3 | — |
| 2017 | Q2 | Q4 | 0,502 | 1,5 | 1,6 | 0,49 | Q3 | 70 |
| 2016 | Q2 | Q4 | 0,569 | 1,4 | 1,7 | — | — | 70 |
| 2015 | Q2 | Q3 | 0,624 | 1,5 | 1,6 | — | — | 70 |
| 2014 | Q2 | Q3 | 0,612 | 1,7 | 1,6 | — | — | 70 |
| 2013 | Q2 | Q3 | 0,621 | 1,6 | 1,7 | — | — | 70 |
| 2012 | Q2 | Q3 | 0,54 | 1,6 | 1,7 | — | — | 70 |
| 2011 | Q2 | Q3 | 0,725 | 1,8 | 1,9 | — | — | 70 |
| 2010 | Q2 | Q3 | 0,636 | 1,8 | 1,6 | — | — | 70 |
| 2009 | — | Q3 | — | 1,8 | 1,5 | — | — | — |
| 2008 | — | Q3 | — | 1,9 | 1,6 | — | — | — |
| 2007 | — | Q4 | — | 1,2 | 1,3 | — | — | — |
| 2006 | — | Q3 | — | 1,2 | — | — | — | — |
| 2005 | — | Q3 | — | 1,4 | — | — | — | — |
| 2004 | — | Q3 | — | 1,1 | — | — | — | — |
| 2003 | — | Q3 | — | 1 | — | — | — | — |
| 2002 | — | Q2 | — | 1,6 | — | — | — | — |
| 2001 | — | Q2 | — | 1,6 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q3 | — | 1 | — | — | — | — |
| 1998 | — | Q3 | — | 0,8 | — | — | — | — |
| 1997 | — | Q3 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 126/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 147/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 152/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 149/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 193/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 227/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 208/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 205/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 203/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 191/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 169/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 170/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 171/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 158/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 154/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 147/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 131/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 155/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 143/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 126/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 132/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 89/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 101/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 115/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 86/157 |